Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 236,832,510 papers from all fields of science
Search
Sign In
Create Free Account
STI571
Known as:
STI 571
, STI-571
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Gleevec
Broader (2)
Imatinib mesylate
imatinib
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
REFLEKSI HISTORIS KONVERSI STI KE UIN
Suheri Suheri
2014
Corpus ID: 171521547
Kehadiran lembaga pendidikan Islam yang berawal dari Pesantren yang melahirkan Madrasah hingga kemudian dilanjutkan kehaliran…
Expand
2010
2010
Interaction in Multidimensional Contingency Tables : An Information Theoretic Approach
H. H. Ku
,
S.
,
Kullback
2010
Corpus ID: 56394635
The problem of interaction in multidimensional contingency tables is inves tigated from the viewpoint of information theory as…
Expand
2007
2007
16. A RANDOMIZED CONTROLLED TRIAL OF THE IMPACT OF EMAIL AND TEXT (SMS) MESSAGES ON THE SEXUAL HEALTH OF YOUNG PEOPLE
M. Lim
,
J. Hocking
,
+4 authors
M. Hellard
2007
Corpus ID: 71705992
Objective: To trial a novel method of sexual health promotion - sending email and mobile phone text messages (SMS) about safe sex…
Expand
2003
2003
Molecular therapeutics: is one promiscuous drug against multiple targets better than combinations of molecule-specific drugs?
C. Arteaga
Clinical Cancer Research
2003
Corpus ID: 26306776
Two manuscripts from the same group in this issue illustrateimportant aspects relevant to the discovery and development of…
Expand
2003
2003
Response to STI571 in chronic myelomonocytic leukemia with platelet derived growth factor beta receptor involvement: a new case report.
V. Pitini
,
C. Arrigo
,
Diana Teti
,
Gaetano Barresi
,
M. Righi
,
G. Alo
Haematologica
2003
Corpus ID: 21870295
Based on its ability to inhibit the tyrosine kinase activity of ABL, as well as the c-kit and the Platelet Derived Growth Factor…
Expand
2003
2003
Is another bcr-abl inhibitor needed for chronic myelogenous leukemia?
E. Sausville
Clinical Cancer Research
2003
Corpus ID: 14324899
The recent success of STI-571 (Imatinib mesylate; Gleevec) in the chronic phase of CML[2][1] is a milestone in the history of…
Expand
Review
2001
Review
2001
Recent success with the tyrosine kinase inhibitor STI-571--lessons for targeted therapy of cancer.
N. Shah
,
C. Sawyers
Current opinion in investigational drugs
2001
Corpus ID: 30742856
2001
2001
KIT (CD117) immunostaining and treatment with STI-571
C. Fletcher
2001
Corpus ID: 71908275
2000
2000
Another possible mechanism of resistance to STI571.
Z. A. Knight
Blood
2000
Corpus ID: 42857731
Le Coutre et al[1][1] report the characterization of a cell line (LAMA84R) that expresses the oncogenic tyrosine kinase Bcr/Abl…
Expand
2000
2000
Molecular biology. Cancer fighter's modus operandi revealed.
J. Marx
Science
2000
Corpus ID: 8243138
Researchers have deciphered how a promising cancer drug acts like a smart bomb, homing in on only a very narrow range of its…
Expand